The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
WITHDRAWN: THERANOVA study: A phase II platform trial of theranostic agents (TA) in solid tumors with active brain metastases (BM).
 
Nathalie Albert
Honoraria - ABX Advanced biochemical compounds; Advanced Accelerator Applications; CarThera; ITM Oncologics; MedSIR; Novartis; OncLive; SERVIER; Telix Pharmaceuticals
Consulting or Advisory Role - ABX Advanced biochemical compounds; Advanced Accelerator Applications; CarThera; ITM Oncologics; MedSIR; Novartis; OncLive; SERVIER; Telix Pharmaceuticals
Research Funding - Novocure; SERVIER; Telix Pharmaceuticals
 
Maria Gion
Consulting or Advisory Role - AstraZeneca; Lilly; Pfizer
Speakers' Bureau - AstraZeneca; Gilead Sciences; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Pfizer; Roche
 
Alfredo Addeo
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Speakers' Bureau - Amgen; AstraZeneca; Lilly
Research Funding - AstraZeneca
 
Thorsten Fuereder
Honoraria - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Merck KGaA; MSD; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; BeiGene; Boehringer Ingelheim; Daiichi Sankyo/Astra Zeneca; Invios; Invios; Janssen; Lilly; Merck KGaA; MSD; PharmaMar; Takeda
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Kura Oncology (Inst); Merck KGaA (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Merck KGaA; MSD
 
Antonio Llombart-Cussac
Stock and Other Ownership Interests - Initia-Research; MAJ3 Capital
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Lilly; MSD; Novartis; Pfizer
Research Funding - Agendia; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
Patents, Royalties, Other Intellectual Property - Her2 as a predictor of response to dual HER2 blockade in the absence of cytotoxic therapy.Aleix Prat, Antonio Llombart, Javier Cortés.US 2019/ 0338368 A1. LICENSED
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Pfizer; Roche; Steamline Therapeutics
 
Rupert Bartsch
Honoraria - Amgen; AstraZeneca; BMSi; Daiichi Sankyo; Eisai; Gilead Sciences; Grunenthal; Lilly; MedMedia; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Stemline Therapeutics
Research Funding - AstraZeneca; Daiichi Sankyo; MSD
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Stemline Therapeutics
 
Jose Guerrero-Martinez
Employment - MedSIR
 
Monica Grau
Employment - MedSIR
 
Anna Rea
Employment - MedSIR
 
Simona Iacobucci
Employment - MedSIR
 
Juan Felipe Slebe Concha
No Relationships to Disclose
 
Giulia Raimondi
Employment - MedSIR
 
Nelleke Tolboom
Honoraria - Telix Pharmaceuticals
Consulting or Advisory Role - Telix Pharmaceuticals
Research Funding - Curium Pharma
 
Felix Sahm
No Relationships to Disclose
 
José Manuel Pérez García
Employment - MedSIR
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Gilead Sciences; Lilly; Merck Sharp & Dohme; Roche; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Roche
 
Matthias Preusser
Honoraria - Abbvie; Adastra Pharmaceuticals; AstraZeneca; Bayer; BMJ Journals; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Medahead; MedMedia; Merck Sharp & Dome; Mundipharma; Novartis; Roche; Sanofi; SERVIER; Telix Pharmaceuticals; Tocagen
Consulting or Advisory Role - AbbVie; Adastra Pharmaceuticals; AstraZeneca; Bayer; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo/Astra Zeneca; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Merck Sharp & Dome; Mundipharma; Novartis; Roche; Sanofi; SERVIER; Tocagen
Research Funding - AbbVie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme; Novartis (Inst); Roche (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Mundipharma; Roche; SERVIER